Public-registry site landscape for NCT02790632, a Subarachnoid Hemorrhage, Aneurysmal study sponsored by Edge Therapeutics Inc. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02790632 (registry record) |
| Sponsor | Edge Therapeutics Inc |
| Condition(s) | Subarachnoid Hemorrhage, Aneurysmal |
| Phase | PHASE3 |
| Listed sites | 79 |
| Site countries | United States, Australia, Austria, Canada, Czechia, Finland, Germany, Hong Kong, Israel, New Zealand, Singapore |
Eichor generates a preliminary site-risk snapshot for NCT02790632 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →